The Gold Trade, May 24
Health Care: Health Services
Biolase Inc (BIOL: NASDAQ)
$4.58 -0.19 | -3.98%
05/24/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| BIOL | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 40.71 | 0.00 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 17.40 | 0.32 | 0.10 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.09 | 0.00 |
Earnings for BIOL:
| EBITDA | -1.00 |
| REVENUE | 57.36M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.00 | $0.01 | $0.05 | $0.20 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $0.00 | $0.02 | $0.05 | $0.21 |
| Low Estimate | $-0.01 | $0.01 | $0.05 | $0.20 |
| Prior Year | $-0.06 | $-0.02 | $-0.10 | $0.05 |
| Growth Rate (Year over Year) | 91.54% | 175.75% | 150.25% | 310.00% |
Portfolios with BIOL
- Portfolio NameUser Type
- UserJaheer
Latest BIOL Headlines from TheStreet
- Biolase's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.09.12 | 01:08 am
Press Releases for BIOL
Partner Headlines for BIOL
- Morning Market Movers - Benzinga 10.03.12 | 09:10 am
- BIOLASE Comments on Recent Market Activity; Reiterates Guidance - Benzinga 06.22.12 | 01:06 pm
